Plant autoimmunity refers to the phenomenon where a plant's immune system mistakenly recognizes its own components as foreign and initiates an immune response against them. This leads to the development of autoimmune-like diseases in plants, impacting their growth, development, and overall health. The plant immune system is a complex network of mechanisms designed to recognize and defend against pathogens. However, in some cases, this system can misfire, causing immune responses to self-components. Autoimmune-like disorders in plants may manifest as abnormal growth patterns, tissue damage, and reduced yield. Research in plant autoimmunity explores the molecular and genetic mechanisms underlying these disorders. Factors such as genetic mutations, environmental stressors, and pathogen interactions can contribute to the development of plant autoimmune responses. Understanding plant autoimmunity is crucial for developing strategies to mitigate its impact on crop productivity and plant health. This field also provides insights into the fundamental processes of plant immunity, contributing to advancements in agriculture and plant biology.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom